Recent data confirm that SARS-CoV-2-specific memory CD8+ T cells are present in the vast majority of patients following recovery from COVID-19 (7–10), and their protective role has been inferred from studies in patients who have had both SARS and MERS (11–13). Here, CD8A is linked to COVID-19.